Iradimed (IRMD) EBT Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,614.00 |
| Dec 31, 2025 | 2,656.00 |
| Sep 30, 2025 | 2,411.00 |
| Jun 30, 2025 | 7,875.00 |
| Mar 31, 2025 | 2,084.00 |
| Dec 31, 2024 | 1,110.00 |
| Sep 30, 2024 | 864.00 |
| Jun 30, 2024 | 837.00 |
| Mar 31, 2024 | 1,076.00 |
| Dec 31, 2023 | 1,006.00 |
| Sep 30, 2023 | 1,925.00 |
| Jun 30, 2023 | 976.00 |
| Mar 31, 2023 | 1,225.00 |
| Dec 31, 2022 | 1,626.00 |
| Sep 30, 2022 | 2,766.00 |
| Jun 30, 2022 | 2,654.00 |
| Mar 31, 2022 | 2,890.00 |
| Dec 31, 2021 | 94.00 |
| Sep 30, 2021 | -538.00 |
| Jun 30, 2021 | -1,486.00 |
| Mar 31, 2021 | -1,999.00 |
| Dec 31, 2020 | -2,991.00 |
| Sep 30, 2020 | -2,956.00 |
| Jun 30, 2020 | -7,885.00 |
| Mar 31, 2020 | -2,343.00 |
| Dec 31, 2019 | 1,686.00 |
| Sep 30, 2019 | 1,596.00 |
| Jun 30, 2019 | -790.00 |
| Mar 31, 2019 | -422.00 |
| Dec 31, 2018 | 279.00 |
| Sep 30, 2018 | 447.00 |
| Jun 30, 2018 | -583.00 |